| Top 50 Most Viewed Posts Last Week |
|---|
|
Today This Week Last Week This Month Last Month
|
1. My69z: Dr. Sacha Project End Date 30-June-2025: "These (1717)  (9) |
| 2. Evil Rabbit: I’ve repeatedly griped/whined/complained, (1426) (21) |
| 3. My69z: 3 yrs ago -- ICI Agreement with major institution (1111) (8) |
| 4. biloxiblues: Summary of Leronlimab’s Path and Regulatory (747) (9) |
| 5. KenChowder: Note from Max Lataillade on LinkedIn in response (736) (39) |
| 6. DJknows: Nice post on LinkedIn by Max Latallaide entitled: (661) (8) |
| 7. Evil Rabbit: I told you to try the brownies on the blue plate, (632) (15) |
| 8. My69z: Canonical immune checkpoint response 2019 & a (614) (4) |
| 9. My69z: Gilead -- 2 drugs: Tuesday, April 29, 2025 U.S. (610) (7) |
| 10. Riztheinvestor: Hey everyone, I just want to take a moment to (607) (20) |
| 11. Katangolo: One of your best posts ER.. Too (595) (4) |
| 12. My69z: Rukobia (fostemsavir) is manufactured by ViiV (565) (3) |
| 13. My69z: Top Drugs To Watch in HIV (2025): There is a lot (547) (4) |
| 14. ohm20: Ohm, in light of conversation regarding this herb (537) (10) |
| 15. Riztheinvestor: If CYDY ever hit $181.20, that would be a (536) (7) |
| 16. MidnightRider: FDA News Release FDA to Issue New (535) (14) |
| 17. Cycl2R: I don’t believe it has been noted here that the (530) (12) |
| 18. MJS719: Thank you brentie for the reminder of how (530) (10) |
| 19. ohm20: They’re also has been suspicion that this (530) (3) |
| 20. My69z: Pembrolizumab (KEYTRUDA) is the only checkpoint (530) (4) |
| 21. ohm20: We had a transfer of manufacturing capabilities (526) (9) |
| 22. misiu143: This we don't know really , doctor who was in (525) (5) |
| 23. DJknows: I'd like to follow up on this because I've come (524) |
| 24. KenChowder: No, that's exactly what he didn't say in March. (522) (19) |
| 25. KenChowder: The CRC ESMO poster will be presented on July (509) (8) |
| 26. Chiro2019: So docs post and the Amazon article If you (509) (8) |
| 27. ohm20: Cytodyn should be filing an MDR application. Look (508) (7) |
| 28. ohm20: My concern has always been her connection to an (506) (9) |
| 29. Riztheinvestor: Lol no meds needed. I figured talking about my (489) (4) |
| 30. SporadicE: Yo Sean, I'm pretty sure JL would not have come (487) (16) |
| 31. Katangolo: Happy Father’s Day to the father’s out there (487) (11) |
| 32. cardamine: Please Dr. L -- shareholder update tomorrow (487) (9) |
| 33. Katangolo: That was my initial suspicion as well, thank you. (485) (1) |
| 34. sunray3: Pretty much, except that the two Mercks are (485) (1) |
| 35. KenChowder: Thank fortune this is a board for longs.... (481) (12) |
| 36. ohm20: World-first "undruggable" cancer treatment enters (481) (22) |
| 37. Respert24: It's through guys like that, and people who are (476) (20) |
| 38. Enjay: With regard to using US manufacturing facilities (471) (10) |
| 39. sean007: "Good for everyone else's shares"...waiting with (471) (2) |
| 40. My69z: Yea, i don't understand why this was/has not been (470) (5) |
| 41. sean007: For those looking for "Expanded access" and (468) (5) |
| 42. Shelly2626: Been long for over a decade GLTA Longs Lets (467) (5) |
| 43. testuser: A Agilent Technologies AA Alcoa Inc. AAN Aaron's (466) |
| 44. Chiro2019: Regarding times investigation...possible (462) (9) |
| 45. Jake2212: Midnight: This FDA news release looks to me like (462) (11) |
| 46. weasel667: Well, as an experienced CYDY shareholder (onboard (461) (11) |
| 47. ohm20: MY question is this,...who appointed her as (461) (2) |
| 48. My69z: Weeks ago FDA said chainging the clarity on BP (458) (3) |
| 49. JPValas: Had a 38 to 1 stock split. (456) |
| 50. chazzledazzle: I recall you used to refer to Tanya Urbach as the (455) (2) |
